lenvatinib,sunitinib,pembrolizumab
merck,pfizer,eisai
['clear trial', 'pembro']
clear trial update of efficacy. longer follow up.
2 years of pembro and efficacy still maintained!
fav group lost benefit #esmo22 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert